['benign prostatic hyperplasia']
['hcp1303 capsule 5/0.2mg', 'hcp1303 capsule 5/0.4mg', 'hgp1201', 'hcp1303 capsule 5/0.2mg placebo', 'hcp1303 capsule 5/0.4mg placebo', 'hgp1201 placebo']

        Inclusion Criteria:

          -  At Visit 1

               1. ≥50 age

               2. BPH(Benign Prostatic Hyperplasia) + Total IPSS(International Prostate Symptom
                  Score) ≥ 13

               3. Abnormal Erectile function ≥ at least 3months based on screening date

          -  At Visit 2 1. Total IPSS ≥ 13

        Exclusion Criteria:

          1. History of hypersensitivity to Tamsulosin or Tadalafil

          2. History of allergy for Sulfonamide

          3. PSA (Prostate Specific Antigen) ≥4ng/mL
      